Xian International Medical Investment Co Ltd (000516) — Cash Flow-to-Debt Ratio
Xian International Medical Investment Co Ltd (000516) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥328.04 Million could theoretically repay 0% of its total liabilities (CN¥6.74 Billion) in one year. See 000516 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Xian International Medical Investment Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Xian International Medical Investment Co Ltd across 28 annual periods. Also explore net asset momentum of Xian International Medical Investment Co to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Xian International Medical Investment Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Xian International Medical Investment Co Ltd. For market capitalisation and broader financial context, see Xian International Medical Investment Co stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | CN¥1.28 Billion | CN¥6.70 Billion | ▲ +35.2% |
| 2024 | 0.14x | CN¥1.01 Billion | CN¥7.16 Billion | ▼ -2.8% |
| 2023 | 0.14x | CN¥1.09 Billion | CN¥7.51 Billion | ▲ +183.1% |
| 2022 | 0.05x | CN¥461.34 Million | CN¥9.01 Billion | ▼ -10.4% |
| 2021 | 0.06x | CN¥456.34 Million | CN¥7.99 Billion | ▲ +880.1% |
| 2020 | 0.01x | CN¥41.33 Million | CN¥7.09 Billion | ▲ +185.5% |
| 2019 | -0.01x | CN¥-34.32 Million | CN¥5.03 Billion | ▲ +98.6% |
| 2018 | -0.50x | CN¥-772.11 Million | CN¥1.53 Billion | ▼ -387.6% |
| 2017 | 0.18x | CN¥386.36 Million | CN¥2.20 Billion | ▼ -17.9% |
| 2016 | 0.21x | CN¥439.27 Million | CN¥2.06 Billion | ▲ +54.6% |
| 2015 | 0.14x | CN¥274.23 Million | CN¥1.98 Billion | ▼ -13.5% |
| 2014 | 0.16x | CN¥305.87 Million | CN¥1.92 Billion | ▲ +13.4% |
| 2013 | 0.14x | CN¥327.86 Million | CN¥2.33 Billion | ▼ -29.2% |
| 2012 | 0.20x | CN¥485.12 Million | CN¥2.44 Billion | ▼ -13.9% |
| 2011 | 0.23x | CN¥468.25 Million | CN¥2.03 Billion | ▲ +32.4% |
| 2010 | 0.17x | CN¥285.94 Million | CN¥1.64 Billion | ▼ -7.7% |
| 2009 | 0.19x | CN¥281.07 Million | CN¥1.49 Billion | ▼ -15.3% |
| 2008 | 0.22x | CN¥234.47 Million | CN¥1.05 Billion | ▼ -19.9% |
| 2007 | 0.28x | CN¥228.70 Million | CN¥820.06 Million | ▲ +55.0% |
| 2006 | 0.18x | CN¥134.58 Million | CN¥747.96 Million | ▲ +26.3% |
| 2005 | 0.14x | CN¥93.79 Million | CN¥658.40 Million | ▼ -17.1% |
| 2004 | 0.17x | CN¥70.17 Million | CN¥408.43 Million | ▼ -12.2% |
| 2003 | 0.20x | CN¥77.42 Million | CN¥395.67 Million | ▼ -26.2% |
| 2002 | 0.27x | CN¥102.53 Million | CN¥386.53 Million | ▼ -6.8% |
| 2001 | 0.28x | CN¥112.92 Million | CN¥396.55 Million | ▲ +132.2% |
| 2000 | 0.12x | CN¥46.74 Million | CN¥381.08 Million | ▲ +24.0% |
| 1999 | 0.10x | CN¥22.00 Million | CN¥222.48 Million | ▼ -51.4% |
| 1998 | 0.20x | CN¥43.35 Million | CN¥213.04 Million | — |